Bardin Hill Management Partners’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bardin Hill Management Partners’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-91,416	Closed	-$6.22M	–	119
2022 Q3	$6.22M	Buy	+91,416	New	+$5.04M	1.43%	20

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bardin Hill Management Partners's GBT Position: Q4 2022 in Review

Bardin Hill Management Partners sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 91,416 shares — an estimated $6.22M sold.

Bardin Hill Management Partners first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $6.22M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Bardin Hill Management Partners reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Bardin Hill Management Partners sold 91,416 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $6.22M.
Bardin Hill Management Partners first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Bardin Hill Management Partners's Global Blood Therapeutics, Inc. position peaked at $6.22M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Bardin Hill Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.